What is the recommended treatment for a migraine episode?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Migraine Episode

For moderate to severe migraine, start combination therapy with a triptan (sumatriptan 50-100 mg) plus an NSAID (naproxen 500-825 mg or ibuprofen 400-800 mg) as first-line treatment, taken as early as possible when headache begins. 1

Initial Treatment Algorithm

Mild Migraine

  • Start with an NSAID alone (ibuprofen 400-800 mg, naproxen 500-825 mg, or aspirin 1000 mg) or acetaminophen 1000 mg 1
  • Alternative: combination of aspirin 250 mg + acetaminophen 250 mg + caffeine 65 mg 1
  • Take medication immediately at headache onset while pain is still mild 1, 2

Moderate to Severe Migraine

  • Use combination therapy from the start: triptan + NSAID (or acetaminophen if NSAIDs contraindicated) 1, 2
  • Specific combinations with strongest evidence:
    • Sumatriptan 50-100 mg + naproxen 500 mg 1, 3
    • Any triptan + ibuprofen 400-800 mg 1
  • This combination provides 130 additional patients per 1000 achieving sustained pain relief at 48 hours compared to either agent alone 3

Dosing Specifics for Triptans

  • Sumatriptan oral: 50-100 mg at onset; may repeat once after 2 hours if needed (maximum 200 mg/24 hours) 4
  • The 100 mg dose does not provide greater efficacy than 50 mg but may have more adverse effects 4
  • For rapid onset or severe nausea/vomiting: subcutaneous sumatriptan 6 mg provides relief within 15 minutes with 59% pain-free at 2 hours 1, 3

Escalation for Treatment Failure

If First-Line Therapy Fails After 2-3 Attacks

  • Try a different triptan within the class—failure of one does not predict failure of others 1, 3
  • Options include: almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, zolmitriptan 1
  • Consider route change (intranasal or subcutaneous) if oral formulations ineffective 1, 3

Second-Line Options for Triptan Failures

  • CGRP antagonists (gepants): rimegepant, ubrogepant, or zavegepant 1, 2
  • Ergot alkaloid: dihydroergotamine (intranasal or IV) 1, 3
  • These should be reserved for patients who do not tolerate or have inadequate response to triptan + NSAID combination 1

Third-Line Option

  • Lasmiditan (ditan class) for patients who have failed all other treatments in this guideline 1

Management of Associated Symptoms

Nausea and Vomiting

  • Add antiemetic 20-30 minutes before analgesic: metoclopramide 10 mg or prochlorperazine 10-25 mg 1, 3
  • These provide synergistic analgesia beyond antiemetic effects through central dopamine receptor antagonism 3
  • For severe vomiting: use non-oral triptan (subcutaneous, intranasal) plus antiemetic 1

Critical Medication Frequency Limits

Limit ALL acute migraine medications to no more than 2 days per week (not 2 attacks per week, but 2 calendar days) 1, 2, 3

  • NSAIDs/acetaminophen: medication overuse headache develops at ≥15 days/month 1
  • Triptans: medication overuse headache develops at ≥10 days/month 1
  • If using acute treatment more frequently, immediately initiate preventive therapy 1, 3

Medications to Avoid

Do not use opioids or butalbital-containing compounds for migraine treatment 1

  • These lead to medication overuse headache, dependency, and loss of efficacy 1, 3
  • They do not address migraine-specific pathophysiology 5

Special Populations

Pregnancy and Breastfeeding

  • Discuss adverse effects of all pharmacologic treatments before prescribing 1
  • Acetaminophen is generally preferred during pregnancy 1
  • Avoid triptans, NSAIDs (especially third trimester), and ergot alkaloids unless benefits clearly outweigh risks 1

Cardiovascular Disease

  • Triptans are contraindicated in ischemic heart disease, previous MI, uncontrolled hypertension, or significant cardiovascular disease 3, 6
  • Use NSAIDs with caution in cardiovascular disease 1
  • Consider gepants (CGRP antagonists) as they lack vasoconstrictive effects 1

Hepatic Impairment

  • Maximum single dose of sumatriptan should not exceed 50 mg in mild to moderate hepatic impairment 4

Common Pitfalls to Avoid

  • Taking medication too late in the attack: Efficacy decreases significantly if treatment is delayed until pain is severe 1, 2, 6
  • Underdosing: Ensure adequate doses (ibuprofen 400-800 mg, not 200 mg; naproxen 500-825 mg; sumatriptan 50-100 mg, not 25 mg) 1, 4
  • Using monotherapy for moderate-severe attacks: Combination therapy is superior to either agent alone 1, 2, 3
  • Not recognizing medication overuse headache: If headaches increase in frequency despite treatment, suspect MOH and transition to preventive therapy 1, 3
  • Trying only one triptan before declaring failure: Different triptans have different pharmacokinetics; trial at least 2-3 before escalating 1, 3

When to Initiate Preventive Therapy

Consider preventive medications if: 1, 3

  • Two or more attacks per month causing disability for ≥3 days
  • Using acute medications more than 2 days per week
  • Inadequate response to optimized acute treatment
  • Contraindications to acute treatments

Lifestyle Modifications (Adjunctive)

  • Maintain hydration and regular meals 1, 2
  • Ensure consistent sleep schedule (7-9 hours) 1, 2
  • Regular moderate-to-intense aerobic exercise 1, 2
  • Stress management with relaxation techniques or mindfulness 1, 2
  • Weight loss if overweight or obese 1, 2
  • Identify and avoid individual migraine triggers 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Migraine Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Symptomatic treatment of migraine: when to use NSAIDs, triptans, or opiates.

Current treatment options in neurology, 2011

Research

Acute Migraine Headache: Treatment Strategies.

American family physician, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.